InvestorsHub Logo
Followers 617
Posts 93704
Boards Moderated 8
Alias Born 11/01/2006

Re: None

Monday, 02/28/2022 9:36:34 AM

Monday, February 28, 2022 9:36:34 AM

Post# of 6725
On February 28, 2022, Arbutus Biopharma Corporation (the "Company") and Genevant Sciences filed a lawsuit in the U.S. District Court for the District of Delaware against Moderna, Inc. (Nasdaq: MRNA) and a Moderna affiliate seeking damages for infringement of U.S. Patent Nos. 8,058,069, 8,492,359, 8,822,668, 9,364,435, 9,504,651, and 11,141,378 in the manufacture and sale of MRNA-1273, Moderna’s vaccine for COVID-19. The patents relate to nucleic acid-lipid particles and lipid vesicles, as well as compositions and methods for their use.


You can lead a horse to water. But you can't make him get down on one knee and do an Al Jolson impression!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABUS News